Elizabeth J Anderson

Abstract 1207: A systematic literature review of the prevalence of PIK3CA mutations and mutation hotspots in HR+/HER2- metastatic breast cancer

T. Warholak, A. Aizer, L. Davis, 2018, Epidemiology.

A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2- Metastatic Breast Cancer.

T. Warholak, A. Aizer, L. Davis, 2019, Clinical breast cancer.

A Systematic Review of the Prevalence and Diagnostic Workup of PIK3CA Mutations in HR+/HER2– Metastatic Breast Cancer

T. Warholak, A. Aizer, L. Davis, 2020, International journal of breast cancer.